Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × Pemetrexed × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 90 Lung Neoplasms 34 Neoplasms 9 Neoplasm Metastasis 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Mesothelioma, Malignant 7 Colorectal Neoplasms 7 Carcinoma 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Mesothelioma 3 Colonic Neoplasms 3 Advanced Solid Tumors 3 Adenocarcinoma 3 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Ovarian Neoplasms 2 Non-Squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 NSCLC 2 Meningeal Carcinomatosis 2 Lung Diseases 2 Carcinoma, Pancreatic Ductal 2 Carcinoma, Bronchogenic 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

trametinib 2 dabrafenib 2 pembrolizumab 1 cobimetinib 1 atezolizumab 1 Vemurafenib 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Paclitaxel 1 Immunoglobulin G 1 Disulfides 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡